# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Approximately 16 million Americans suffer from dry eye disease with the U.S. market for dry eye treatment projected to reach $4...
NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of ...
Ordered product sales of Avenova®-branded products on Amazon.com set back-to-back records in March and April 2024Enhanced marke...
NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of ...